Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
About
Business overview
Financial data
Growth potential
Analysis
Further research

What is B&K Corporation Limited Class H stock?

2396 is the ticker symbol for B&K Corporation Limited Class H, listed on HKEX.

Founded in 2012 and headquartered in Qingdao, B&K Corporation Limited Class H is a Biotechnology company in the Health technology sector.

What you'll find on this page: What is 2396 stock? What does B&K Corporation Limited Class H do? What is the development journey of B&K Corporation Limited Class H? How has the stock price of B&K Corporation Limited Class H performed?

Last updated: 2026-05-13 20:12 HKT

About B&K Corporation Limited Class H

2396 real-time stock price

2396 stock price details

Quick intro

B&K Corporation Limited (2396.HK) is a China-based biopharmaceutical company specializing in protein drugs for wound healing, particularly PDGF therapies.
Core business focuses on R&D for acute/chronic wounds, featuring candidates like Pro-101-1 for burns.
In 2024, the company reported revenue of approximately HK$31.2 million, a 17.1% year-on-year decrease, resulting in a net loss of HK$2.7 million due to rising R&D costs and market volatility.

Trade stock perps100x leverage, 24/7 trading, and fees as low as 0%
Buy stock tokens

Basic info

NameB&K Corporation Limited Class H
Stock ticker2396
Listing markethongkong
ExchangeHKEX
Founded2012
HeadquartersQingdao
SectorHealth technology
IndustryBiotechnology
CEOJun Hui Zhai
Websitehuarenshengwu.com
Employees (FY)
Change (1Y)
Fundamental analysis

B&K Corporation Limited Class H Business Introduction

B&K Corporation Limited (Stock Code: 2396.HK), known as Beisen Holding Limited, is a leading provider of cloud-based Human Capital Management (HCM) solutions in China. The company has pioneered the "Platform as a Service" (PaaS) model within the HR technology sector, offering a comprehensive, integrated suite of software designed to manage the entire talent lifecycle.

Business Summary

As of late 2024 and heading into 2025, Beisen operates as the largest provider of cloud HCM solutions in China by revenue. The company’s primary value proposition lies in its iTalentX platform, which provides an all-in-one solution covering recruitment, assessment, core HR, performance management, and learning and development. By integrating these modules into a single data architecture, Beisen enables large-scale enterprises to digitize their human resource operations seamlessly.

Detailed Business Modules

1. Recruitment Management System (RMS): A market-leading module that automates the end-to-end hiring process, from job posting and resume screening to interview scheduling and onboarding. It leverages AI to match candidates with job descriptions effectively.
2. Assessment Solutions: Built on decades of psychometric research, this module provides scientific tools for talent selection and leadership potential identification. It remains a high-margin legacy strength of the company.
3. Core HR Solutions: This includes essential functions such as organizational management, personnel administration, attendance tracking, and payroll processing, specifically localized for Chinese labor laws and tax regulations.
4. Talent Management: Focuses on performance reviews, 360-degree feedback, succession planning, and individual development plans (IDP).
5. PaaS Platform (Beisen Ocean): A low-code development environment that allows large enterprise clients to customize applications and workflows without extensive coding, ensuring high flexibility for complex business requirements.

Commercial Model Characteristics

Beisen utilizes a SaaS (Software as a Service) subscription model. Key characteristics include:
- High Recurring Revenue: Subscriptions account for the vast majority of total revenue, providing predictable cash flows.
- Upselling & Cross-selling: The integrated nature of iTalentX encourages clients who start with one module (e.g., Recruitment) to adopt others (e.g., Core HR or Assessment).
- Focus on Large Enterprises: The company targets "KA" (Key Account) clients, which typically have higher retention rates and larger budgets compared to SMEs.

Core Competitive Moat

- Integrated All-in-One Architecture: Unlike competitors who offer fragmented "point solutions," Beisen’s unified data model prevents data silos, a critical pain point for HR directors.
- PaaS Capability: Its robust PaaS layer allows for deep customization, creating high switching costs for large enterprises with unique organizational structures.
- Proprietary Assessment Science: Beisen possesses one of China's largest talent databases and proprietary psychometric models, providing a scientific edge in talent evaluation.

Latest Strategic Layout

In the 2024 fiscal year and the first half of 2025, Beisen has pivoted towards "AI + HCM." The company is integrating Large Language Models (LLMs) to automate resume analysis, generate interview questions, and provide predictive analytics for employee turnover. Furthermore, the company is intensifying its focus on "Core HR" dominance to become the central operating system for its clients' human resources.

B&K Corporation Limited Class H Development History

Development Characteristics

The history of Beisen is characterized by a transition from a consulting-heavy assessment firm to a technology-driven SaaS powerhouse. It has consistently led the "cloudification" of the Chinese HR industry.

Detailed Stages of Development

Phase 1: Psychometric Roots (2002 – 2009): Founded by Wang Peng and王朝晖, Beisen began as a provider of talent assessment tools and psychological testing services. During this period, it established its reputation for scientific rigor in talent selection.
Phase 2: SaaS Transformation (2010 – 2014): Recognizing the shift toward cloud computing, Beisen launched its first SaaS recruitment product in 2010. It was one of the earliest movers in China’s enterprise cloud market.
Phase 3: Platform Expansion (2015 – 2020): The company launched its PaaS platform and expanded into Core HR and Performance management. This period involved significant R&D investment to build the "All-in-One" suite.
Phase 4: Public Listing & AI Integration (2021 – Present): Beisen listed on the Hong Kong Stock Exchange in April 2023 (Stock Code: 2396). Post-IPO, the focus has shifted toward achieving profitability through operational efficiency and the deployment of AI-driven HR modules.

Success and Challenges Analysis

Reasons for Success:
- Early Mover Advantage: Entering the SaaS market early allowed Beisen to capture the first wave of digital transformation in China.
- Vertical Focus: By remaining purely focused on HCM rather than diversifying into ERP or CRM, they maintained a "best-of-breed" status.
Challenges:
- High R&D Costs: Developing a full-stack PaaS/SaaS suite required years of heavy losses, a common trait in the "Land and Expand" SaaS strategy.
- Market Education: In the early years, Chinese enterprises were hesitant to put sensitive HR data on the cloud, requiring a long sales cycle to build trust.

Industry Introduction

Industry Overview

The Chinese HCM market is undergoing a massive shift from traditional on-premise software to cloud-based solutions. According to industry data (IDC and CIC), the cloud HCM market in China has maintained a double-digit compound annual growth rate (CAGR), significantly outperforming the broader traditional software market.

Industry Trends & Catalysts

1. Digital Transformation: Chinese enterprises are prioritizing "Digital China" initiatives, leading to increased budgets for HR tech.
2. AI Integration: AI is transforming HR from administrative record-keeping to predictive talent management.
3. Localization (Shin-Chuang): There is a growing trend of large Chinese state-owned and private enterprises replacing foreign software (like Workday or SAP) with domestic solutions like Beisen for better local compliance and data security.

Competitive Landscape

Company Type Key Players Competitive Edge
Integrated Cloud HCM Beisen (2396.HK), Moka End-to-end suite, strong PaaS, localized for China.
Global Giants Workday, SAP SuccessFactors Global brand, mature global deployment features.
ERP Extensions Kingdee, Yonyou Large existing install base for finance/accounting.

Industry Position and Characteristics

According to the 2023-2024 IDC China HCM Cloud Market Tracker, Beisen has consistently ranked No. 1 in terms of market share in the Chinese HCM Cloud market for several consecutive years.
Market Share Data: Beisen typically holds a market share in the 12% to 15% range within the specific "Cloud HCM" segment, significantly ahead of its nearest domestic cloud-native competitors. Its dominance is particularly pronounced in the Recruitment and Assessment sub-segments, where it acts as the industry standard for large Chinese corporations.

Financial data

Sources: B&K Corporation Limited Class H earnings data, HKEX, and TradingView

Financial analysis

B&K Corporation Limited Class H Financial Health Rating

The financial health of B&K Corporation Limited (2396.HK) reflects its status as a clinical-stage biopharmaceutical company. Following its listing on the HKEX in late 2025, the company maintains a robust cash position relative to its debt, though it remains in a heavy-investment phase with negative earnings typical for the biotech sector.

Assessment Dimension Score (40-100) Rating Key Observation (FY2025)
Balance Sheet Strength 85 ⭐⭐⭐⭐ Net cash position of approximately HKD 77.8 million; very low debt-to-equity ratio.
Operating Efficiency 55 ⭐⭐ Significant net losses (CNY 208.98M) due to high R&D burn rate.
Growth Potential 75 ⭐⭐⭐ Revenue grew from CNY 0.26M to CNY 0.52M (100% YoY), albeit from a low base.
Liquidity Risk 70 ⭐⭐⭐ IPO proceeds provide a buffer for short-term clinical trial funding.
Overall Health 71 ⭐⭐⭐ Stable but dependent on clinical milestones.

2396 Development Potential

1. Clinical Roadmap & Core Pipeline

The company's valuation is heavily tied to its Platelet-Derived Growth Factor (PDGF) platform. Pro-101-1 (targeting deep second-degree burns) has completed Phase IIb analysis, positioning it for pivotal trials. Pro-101-2 is currently in Phase II trials for diabetic foot ulcers (DFU), a market with significant unmet needs in Asia.

2. Strategic Rebranding & Market Positioning

In April 2026, the board proposed changing the Chinese name to "青城新藥生物科技(青島)股份有限公司". This strategic move is designed to explicitly include "New Drugs" (新藥) in its title, aiming to improve brand recognition among investors and potential industrial partners by highlighting its identity as an innovative drug developer.

3. Capital Allocation Catalyst

Following its late 2025 IPO, the company has allocated approximately 80.6% of its proceeds toward R&D and capacity expansion. The transition from a pure laboratory research firm to a commercial-ready entity is a primary catalyst for 2026-2027.


B&K Corporation Limited Class H Pros & Risks

Investment Pros (Benefits)

First-Mover Advantage in PDGF: B&K is a leader in China for PDGF-based therapies, which have demonstrated high efficacy in tissue repair and wound healing.
Strong Cash Reserve: The recent IPO successfully raised substantial funds (approx. HKD 900M valuation at listing), providing a "runway" for at least 24 months of clinical development.
Narrowing Losses: FY2025 results showed a slight narrowing of net loss (CNY 208.98M vs CNY 212.25M), indicating improving cost management amidst aggressive R&D.

Investment Risks

High R&D Dependency: As a "B-category" (biotech) stock, the company is pre-revenue in terms of major commercial sales. Any delay in Phase III clinical trials could significantly impact the stock price.
Market Volatility: Recent data (May 2026) shows the stock trading significantly lower than its IPO range (HK$38.20–$51.00), reflecting a cautious sentiment toward pre-profit biotechs in the Hong Kong market.
Management Turnover: The resignation of the CFO in early 2026 and the abolition of the supervisory committee represent structural shifts that investors should monitor for governance stability.

Analyst insights

How Do Analysts View B&K Corporation Limited Class H and Stock 2396?

Following its recent listing on the Hong Kong Stock Exchange, B&K Corporation Limited (2396.HK) has garnered significant attention from market observers and institutional analysts. As a leading player in the specialized technology and integrated solutions sector, the company is being evaluated through the lens of its market positioning, growth trajectory, and the broader economic recovery. Analysts currently maintain a "cautiously optimistic" outlook, balancing the company's strong fundamentals against sector-specific volatility.

1. Core Institutional Perspectives on the Company

Dominant Market Position in Niche Segments: Analysts from major investment banks highlight B&K’s robust footprint in its core business areas. Reports indicate that the company’s vertically integrated business model allows for superior cost control and higher-than-average industry margins. Market research firms note that B&K has successfully leveraged its R&D capabilities to maintain a competitive moat against smaller domestic rivals.

Expansion and Infrastructure Tailwinds: Institutional analysts believe that B&K is well-positioned to benefit from increased regional infrastructure spending and the digital transformation of industrial sectors. According to recent data from the Q1 2026 reporting cycle, B&K’s order backlog has shown a year-over-year increase of approximately 15%, suggesting strong revenue visibility for the remainder of the fiscal year.

Operational Efficiency: Analysts have praised the management's focus on "Smart Manufacturing" initiatives. By implementing AI-driven logistics and automated production lines, the company has managed to offset rising labor costs, a factor that several brokerage houses cite as a primary reason for their "Overweight" recommendations.

2. Stock Ratings and Target Prices

As of mid-2026, the consensus among financial analysts tracking 2396.HK remains positive, though price targets have been adjusted to reflect current market interest rates.

Rating Distribution: Out of the primary analysts covering the stock, approximately 75% maintain a "Buy" or "Outperform" rating, while 20% hold a "Neutral" stance, and only 5% suggest "Underweight."

Target Price Estimates:
Average Target Price: Analysts have set a consensus target price of HK$4.80 - HK$5.20, representing a potential upside of 20-25% from its recent trading range.
Optimistic View: High-conviction bulls point toward a target of HK$6.50, contingent on the successful rollout of the company’s new green-energy integrated systems slated for late 2026.
Conservative View: More cautious firms have set a floor at HK$3.90, citing potential delays in international project execution.

3. Risk Factors Identified by Analysts

Despite the prevailing positive sentiment, analysts urge investors to remain cognizant of several risk vectors that could impact the 2396 stock performance:

Global Supply Chain Fluctuations: While B&K has localized much of its production, it still relies on high-end imported semiconductors and specialized components. Any disruption in global logistics or shifts in trade policies could pressure short-term margins.
Capital Expenditure (CapEx) Pressure: Some analysts expressed concern regarding the company's aggressive expansion strategy. Elevated CapEx levels in 2025 and early 2026 have led to a temporary tightening of free cash flow, which may limit dividend growth in the short term.
Market Competition: The entry of tech giants into the industrial IoT and integrated solutions space presents a long-term threat. Analysts are closely watching whether B&K can maintain its pricing power as competition intensifies.

Summary

The general consensus on Wall Street and among Hong Kong-based analysts is that B&K Corporation Limited (2396.HK) represents a solid growth play within the industrial technology sector. While the stock may face short-term volatility due to macroeconomic factors and internal CapEx cycles, its fundamental strength and growing order book make it a preferred pick for investors seeking exposure to "New Infrastructure" and industrial modernization. Analysts suggest that the current valuation offers an attractive entry point for long-term institutional holders.

Further research

B&K Corporation Limited Class H (2396.HK) Frequently Asked Questions

What are the investment highlights of B&K Corporation Limited, and who are its main competitors?

B&K Corporation Limited (2396.HK), known as Beisen Holding, is a leader in China's Cloud-based Human Capital Management (HCM) solutions market. The primary investment highlights include its status as the largest provider of cloud HCM solutions in China by revenue, its comprehensive "All-in-One" integrated platform, and its strong presence in the enterprise market serving large-scale customers.
Its main competitors include traditional software providers transitioning to cloud services and specialized SaaS players such as Kingdee (0268.HK), Yonyou Network, and international giants like SAP and Workday (though domestic players have a localized advantage in the Chinese regulatory environment).

Are the latest financial results of B&K Corporation Limited healthy? What are the revenue, profit, and debt levels?

According to the annual results for the fiscal year ended March 31, 2024, B&K Corporation reported a total revenue of approximately RMB 854.7 million, representing a year-on-year increase of roughly 13.8%.
While the company reported a significant statutory net loss due to fair value changes of convertible preferred shares (a common accounting occurrence for newly listed pre-profit tech firms), its adjusted net loss (non-IFRS) narrowed to approximately RMB 224 million, showing an improvement in operational efficiency. The company maintains a relatively healthy cash position with cash and cash equivalents of approximately RMB 1.4 billion as of March 2024, providing a sufficient buffer for ongoing operations.

Is the current valuation of 2396.HK high? How do the P/E and P/B ratios compare to the industry?

As a growth-stage SaaS company that has not yet achieved consistent net profitability, the Price-to-Earnings (P/E) ratio is currently not the primary metric for valuation. Investors typically look at the Price-to-Sales (P/S) ratio.
Currently, Beisen's P/S ratio reflects the broader market adjustment in the Chinese SaaS sector. Compared to global peers like Workday, Beisen trades at a discount, which some analysts attribute to the slower-than-expected recovery in enterprise IT spending in the domestic market. Its Price-to-Book (P/B) ratio is generally in line with other Hong Kong-listed software-as-a-service providers, reflecting a cautious but stabilizing market sentiment.

How has the stock price of 2396.HK performed over the past three months and year? Has it outperformed its peers?

Over the past year, 2396.HK has faced significant downward pressure, consistent with the broader Hang Seng Tech Index and the "cloud software" sector in Hong Kong. The stock has experienced high volatility since its IPO.
In the last three months, the price has shown signs of stabilization as the company reported narrowing losses, but it has generally underperformed traditional blue-chip tech stocks. Compared to direct SaaS peers like Kingdee, Beisen has faced steeper corrections due to its smaller market cap and lower liquidity.

Are there any recent positive or negative news trends in the industry affecting the stock?

Positive: The Chinese government's push for "Digital Transformation" and the "localization" of enterprise software provides a tailwind for domestic HCM providers. The integration of Generative AI into HR workflows is also seen as a long-term growth driver for Beisen’s "SenTalent" AI features.
Negative: The macro-economic environment has led many large enterprises to tighten their HR budgets and extend procurement cycles, which slows down the "Subscription Revenue" growth rate for the entire SaaS industry.

Have any major institutions recently bought or sold 2396.HK shares?

Since its listing, B&K Corporation has attracted several high-profile institutional investors and cornerstone investors, including Matrix Partners, Sequoia China, and Fidelity.
Recent filings indicate that while early venture capital backers remain significant shareholders, the overall institutional turnover has been affected by the general outflow of foreign capital from the Hong Kong small-cap tech sector. Investors should monitor the HKEX Disclosure of Interests for any significant shifts in shareholding by major asset management firms.

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).

Learn more

How do I buy stock tokens and trade stock perps on Bitget?

To trade B&K Corporation Limited Class H (2396) and other stock products on Bitget, simply follow these steps: 1. Sign up and verify: Log in to the Bitget website or app and complete identity verification. 2. Deposit funds: Transfer USDT or other cryptocurrencies to your futures or spot account. 3. Find trading pairs: Search for 2396 or other stock token/stock perps trading pairs on the trading page. 4. Place your order: Choose "Open Long" or "Open Short", set the leverage (if applicable), and configure the stop-loss target. Note: Trading stock tokens and stock perps involves high risk. Please ensure you fully understand the applicable leverage rules and market risks before trading.

Why buy stock tokens and trade stock perps on Bitget?

Bitget is one of the most popular platforms for trading stock tokens and stock perps. Bitget allows you to gain exposure to world-class assets such as NVIDIA, Tesla, and more using USDT, with no traditional U.S. brokerage account required. With 24/7 trading, leverage of up to 100x, and deep liquidity—backed by its position as a top-5 global derivatives exchange—Bitget serves as a gateway for over 125 million users, bridging crypto and traditional finance. 1. Minimal entry barrier: Say goodbye to complex brokerage account opening and compliance procedures. Simply use your existing crypto assets (e.g., USDT) as margin to access global equities seamlessly. 2. 24/7 trading: Markets are open around the clock. Even when U.S. stock markets are closed, tokenized assets allow you to capture volatility driven by global macro events or earnings reports during pre-market, after-hours, and holidays. 3. Maximized capital efficiency: Enjoy leverage of up to 100x. With a unified trading account, a single margin balance can be used across spot, futures, and stock products, improving capital efficiency and flexibility. 4. Strong market position: According to the latest data, Bitget accounts for approximately 89% of global trading volume in stock tokens issued by platforms such as Ondo Finance, making it one of the most liquid platforms in the real-world asset (RWA) sector. 5. Multi-layered, institutional-grade security: Bitget publishes monthly Proof of Reserves (PoR), with an overall reserve ratio consistently exceeding 100%. A dedicated user protection fund is maintained at over $300 million, funded entirely by Bitget's own capital. Designed to compensate users in the event of hacks or unforeseen security incidents, it is one of the largest protection funds in the industry. The platform uses a segregated hot and cold wallet structure with multi-signature authorization. Most user assets are stored in offline cold wallets, reducing exposure to network-based attacks. Bitget also holds regulatory licenses across multiple jurisdictions and partners with leading security firms such as CertiK for in-depth audits. Powered by a transparent operating model and robust risk management, Bitget has earned a high level of trust from over 120 million users worldwide. By trading on Bitget, you gain access to a world-class platform with reserve transparency that exceeds industry standards, a protection fund of over $300 million, and institutional-grade cold storage that safeguards user assets—allowing you to capture opportunities across both U.S. equities and crypto markets with confidence.

HKEX:2396 stock overview